The University of Chicago Header Logo

Radhika R. Peddinti

TitleAssociate Professor
InstitutionUniversity of Chicago
DepartmentPediatrics-Hematology and Oncology
AddressChicago IL 60637
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Peddinti R. Disease-Modifying Therapies for Sickle Cell Disease-An Overview. Pediatr Ann. 2024 Feb; 53(2):e52-e55. PMID: 38302121.
      Citations:    Fields:    Translation:HumansPHPublic Health
    2. Peddinti R. Sickle Cell Disease: Past, Present, and Future. Pediatr Ann. 2024 02; 53(2):e42. PMID: 38302119.
      Citations:    Fields:    Translation:Humans
    3. Sharma A, Boelens JJ, Cancio M, Hankins JS, Bhad P, Azizy M, Lewandowski A, Zhao X, Chitnis S, Peddinti R, Zheng Y, Kapoor N, Ciceri F, Maclachlan T, Yang Y, Liu Y, Yuan J, Naumann U, Yu VWC, Stevenson SC, De Vita S, LaBelle JL. CRISPR-Cas9 Editing of the HBG1 and HBG2 Promoters to Treat Sickle Cell Disease. N Engl J Med. 2023 Aug 31; 389(9):820-832. PMID: 37646679; PMCID: PMC10947132.
      Citations: 4     Fields:    Translation:AnimalsCellsCTClinical Trials
    4. Lapping-Carr G, Gemel J, Mao Y, Sparks G, Harrington M, Peddinti R, Beyer EC. Insights image for "Circulating extracellular vesicles from patients with acute chest syndrome disrupt adherens junctions between endothelial cells". Pediatr Res. 2021 03; 89(4):1036. PMID: 33790407.
      Citations: 1     Fields:    Translation:HumansCells
    5. Lapping-Carr G, Gemel J, Mao Y, Sparks G, Harrington M, Peddinti R, Beyer EC. Circulating extracellular vesicles from patients with acute chest syndrome disrupt adherens junctions between endothelial cells. Pediatr Res. 2021 03; 89(4):776-784. PMID: 32454519; PMCID: PMC8261277.
      Citations: 5     Fields:    Translation:HumansCells
    6. Jung JM, Peddinti R. Lead Toxicity in the Pediatric Patient with Sickle Cell Disease: Unique Risks and Management. Pediatr Ann. 2018 Jan 01; 47(1):e36-e40. PMID: 29323695.
      Citations: 2     Fields:    Translation:Humans
    7. Lapping-Carr G, Khalyfa A, Rangel S, Darlington W, Beyer EC, Peddinti R, Cunningham JM, Gozal D. Exosomes contribute to endothelial integrity and acute chest syndrome risk: Preliminary findings. Pediatr Pulmonol. 2017 Nov; 52(11):1478-1485. PMID: 28486752; PMCID: PMC5653417.
      Citations: 12     Fields:    Translation:HumansCells
    8. Sokol E, Obringer E, Palama B, Hageman J, Peddinti R. Outpatient Management of Febrile Children With Sickle Cell Disease. Clin Pediatr (Phila). 2016 Mar; 55(3):268-71. PMID: 26149843.
      Citations: 2     Fields:    Translation:Humans
    9. Sokol E, Peddinti R. Causes and Diagnosis of Abnormal Vaginal Bleeding. Pediatr Ann. 2015 Jul; 44(7):e164-7. PMID: 26171705.
      Citations:    Fields:    Translation:Humans
    10. Ostler KR, Yang Q, Looney TJ, Zhang L, Vasanthakumar A, Tian Y, Kocherginsky M, Raimondi SL, DeMaio JG, Salwen HR, Gu S, Chlenski A, Naranjo A, Gill A, Peddinti R, Lahn BT, Cohn SL, Godley LA. Truncated DNMT3B isoform DNMT3B7 suppresses growth, induces differentiation, and alters DNA methylation in human neuroblastoma. Cancer Res. 2012 Sep 15; 72(18):4714-23. PMID: 22815530; PMCID: PMC3445765.
      Citations: 22     Fields:    Translation:HumansAnimalsCells
    11. Kakodkar NC, Peddinti RR, Tian Y, Guerrero LJ, Chlenski A, Yang Q, Salwen HR, Maitland ML, Cohn SL. Sorafenib inhibits neuroblastoma cell proliferation and signaling, blocks angiogenesis, and impairs tumor growth. Pediatr Blood Cancer. 2012 Oct; 59(4):642-7. PMID: 22147414.
      Citations: 15     Fields:    Translation:AnimalsCells
    12. Kakodkar NC, Peddinti R, Kletzel M, Tian Y, Guerrero LJ, Undevia SD, Geary D, Chlenski A, Yang Q, Salwen HR, Cohn SL. The quinoxaline anti-tumor agent (R+)XK469 inhibits neuroblastoma tumor growth. Pediatr Blood Cancer. 2011 Jan; 56(1):164-7. PMID: 20860039; PMCID: PMC4116189.
      Citations: 6     Fields:    Translation:HumansCells
    13. Batra S, Gupta A, Peddinti R. A 20-year-old male with back pain. Neuroblastoma. Pediatr Ann. 2010 Oct; 39(10):610-3. PMID: 20954606.
      Citations:    Fields:    Translation:Humans
    14. Chlenski A, Guerrero LJ, Peddinti R, Spitz JA, Leonhardt PT, Yang Q, Tian Y, Salwen HR, Cohn SL. Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors. Mol Cancer. 2010 Jun 04; 9:138. PMID: 20525313; PMCID: PMC2895596.
      Citations: 31     Fields:    Translation:HumansAnimalsCells
    15. Zeine R, Salwen HR, Peddinti R, Tian Y, Guerrero L, Yang Q, Chlenski A, Cohn SL. Presence of cancer-associated fibroblasts inversely correlates with Schwannian stroma in neuroblastoma tumors. Mod Pathol. 2009 Jul; 22(7):950-8. PMID: 19407854; PMCID: PMC3347894.
      Citations: 22     Fields:    Translation:HumansAnimalsCells
    16. Peddinti R, Zeine R, Luca D, Seshadri R, Chlenski A, Cole K, Pawel B, Salwen HR, Maris JM, Cohn SL. Prominent microvascular proliferation in clinically aggressive neuroblastoma. Clin Cancer Res. 2007 Jun 15; 13(12):3499-506. PMID: 17575212.
      Citations: 18     Fields:    Translation:Humans
    17. Chlenski A, Guerrero LJ, Yang Q, Tian Y, Peddinti R, Salwen HR, Cohn SL. SPARC enhances tumor stroma formation and prevents fibroblast activation. Oncogene. 2007 Jul 05; 26(31):4513-22. PMID: 17260013.
      Citations: 26     Fields:    Translation:AnimalsCells
    Peddinti's Networks
    Click the
    buttons for more information and interactive visualizations!
    Concepts (110)
    Co-Authors (10)
    Similar People (60)
    Same Department Expand Description
    Physical Neighbors